Pharmaceutical composition, methods for treating and uses thereof

US11666590B2 · kind B2 · utility

Assignee

• Boehringer Ingelheim International GmbH · DE

Inventors

• Uli Christian BROEDL · Oakville, CA
• Odd-Erik JOHANSEN · Måløy, NO
• Eric Williams MAYOUX · Gambais, FR
• Nima SOLEYMANLOU · Sherwood Park, CA
• Maximilian von EYNATTEN · Wiesbaden, DE
• Hans-Juergen WOERLE · Munich, DE
• David Z.I. CHERNEY · Toronto, CA
• Bruce A. PERKINS · Toronto, CA

Key dates

• Filing date: Nov 10, 2020
• Grant date: Jun 6, 2023
• Expiry date: Nov 10, 2040

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention relates to certain SGLT-2 inhibitors for treating, preventing, protecting against and/or delaying the progression of chronic kidney disease in patients, for example patients with prediabetes, type 1 or type 2 diabetes mellitus.